Joe Cohen

10.5k total citations · 2 hit papers
55 papers, 4.8k citations indexed

About

Joe Cohen is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and Immunology. According to data from OpenAlex, Joe Cohen has authored 55 papers receiving a total of 4.8k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Public Health, Environmental and Occupational Health, 21 papers in Epidemiology and 20 papers in Immunology. Recurrent topics in Joe Cohen's work include Malaria Research and Control (29 papers), vaccines and immunoinformatics approaches (18 papers) and HIV Research and Treatment (17 papers). Joe Cohen is often cited by papers focused on Malaria Research and Control (29 papers), vaccines and immunoinformatics approaches (18 papers) and HIV Research and Treatment (17 papers). Joe Cohen collaborates with scholars based in United States, Belgium and United Kingdom. Joe Cohen's co-authors include D. Gray Heppner, Kent E. Kester, Urszula Krzych, W. Ripley Ballou, Nathalie Garçon, W. Ripley Ballou, Gérald Voss, José A. Stoute, Stephen M. Howell and Stacey J. Howell and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and The Lancet.

In The Last Decade

Joe Cohen

55 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria

1997 652 citations José A. Stoute, M. Slaoui et al. New England Journal of Medicine profile →
Does A Kinematically Aligned Total Knee Arthroplasty Restore Function Without Failure Regardless of Alignment Category?

2012 361 citations Joe Cohen et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Joe Cohen United States	36	2.6k	1.8k	1.6k	963	862	55	4.8k
Manuel A. Patarroyo Colombia	28	1.9k 0.7×	1.1k 0.6×	1.4k 0.9×	976 1.0×	742 0.9×	291	4.1k
Michael Theisen Denmark	44	3.2k 1.3×	1.9k 1.1×	1.3k 0.8×	840 0.9×	1.1k 1.3×	163	5.4k
Christian F. Ockenhouse United States	44	3.8k 1.5×	2.0k 1.1×	1.5k 0.9×	910 0.9×	680 0.8×	91	5.7k
Martha Sedegah United States	35	2.8k 1.1×	2.4k 1.4×	2.1k 1.3×	826 0.9×	709 0.8×	106	5.2k
Nathalie Garçon Belgium	34	991 0.4×	2.8k 1.6×	1.7k 1.0×	1.7k 1.8×	1.3k 1.5×	67	5.3k
Walter R. Weiss United States	28	1.6k 0.6×	1.9k 1.0×	1.2k 0.8×	561 0.6×	468 0.5×	52	3.7k
Kent E. Kester United States	34	2.8k 1.1×	1.6k 0.9×	1.8k 1.1×	813 0.8×	769 0.9×	54	4.7k
W. Ripley Ballou United States	32	2.1k 0.8×	1.1k 0.6×	1.1k 0.7×	749 0.8×	662 0.8×	48	3.5k
Rhea N. Coler United States	46	1.8k 0.7×	3.1k 1.7×	1.6k 1.0×	2.9k 3.0×	2.6k 3.0×	133	6.7k
Yupin Charoenvit United States	35	2.4k 0.9×	1.9k 1.1×	1.9k 1.1×	698 0.7×	496 0.6×	65	4.5k

Countries citing papers authored by Joe Cohen

Since Specialization

Citations

This map shows the geographic impact of Joe Cohen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joe Cohen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joe Cohen more than expected).

Fields of papers citing papers by Joe Cohen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joe Cohen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joe Cohen. The network helps show where Joe Cohen may publish in the future.

Co-authorship network of co-authors of Joe Cohen

This figure shows the co-authorship network connecting the top 25 collaborators of Joe Cohen. A scholar is included among the top collaborators of Joe Cohen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Joe Cohen. Joe Cohen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lorin, Clarisse, Yannick Vanloubbeeck, Marguerite Koutsoukos, et al.. (2015). Heterologous Prime-Boost Regimens with a Recombinant Chimpanzee Adenoviral Vector and Adjuvanted F4 Protein Elicit Polyfunctional HIV-1-Specific T-Cell Responses in Macaques. PLoS ONE. 10(4). e0122835–e0122835. 9 indexed citations

Leroux‐Roels, Geert, Isabel Leroux‐Roels, Frédéric Clément, et al.. (2014). Evaluation of the immune response to RTS,S/AS01 and RTS,S/AS02 adjuvanted vaccines. Human Vaccines & Immunotherapeutics. 10(8). 2211–2219. 45 indexed citations

Cavassini, Matthias, R Audran, Anne‐Christine Thierry, et al.. (2014). Safety and immunogenicity of the M72/AS01 candidate tuberculosis vaccine in HIV-infected adults on combination antiretroviral therapy. AIDS. 28(12). 1769–1781. 34 indexed citations

Kester, Kent E., D. Gray Heppner, Philippe Moris, et al.. (2014). Sequential Phase 1 and Phase 2 randomized, controlled trials of the safety, immunogenicity and efficacy of combined pre-erythrocytic vaccine antigens RTS,S and TRAP formulated with AS02 Adjuvant System in healthy, malaria naïve adults. Vaccine. 32(49). 6683–6691. 32 indexed citations

Vanloubbeeck, Yannick, Sathit Pichyangkul, Kosol Yongvanitchit, et al.. (2013). Comparison of the immune responses induced by soluble and particulate Plasmodium vivax circumsporozoite vaccine candidates formulated in AS01 in rhesus macaques. Vaccine. 31(52). 6216–6224. 31 indexed citations

Spertini, François, R Audran, Opokua Ofori‐Anyinam, et al.. (2012). The candidate tuberculosis vaccine Mtb72F/AS02 in PPD positive adults: A randomized controlled phase I/II study. Tuberculosis. 93(2). 179–188. 42 indexed citations

Lumsden, Joanne M., Robert Schwenk, Lisa Rein, et al.. (2011). Protective Immunity Induced with the RTS,S/AS Vaccine Is Associated with IL-2 and TNF-α Producing Effector and Central Memory CD4+ T Cells. PLoS ONE. 6(7). e20775–e20775. 68 indexed citations

Aíde, Pedro, John J. Aponte, Montse Renom, et al.. (2010). Safety, Immunogenicity and Duration of Protection of the RTS,S/AS02D Malaria Vaccine: One Year Follow-Up of a Randomized Controlled Phase I/IIb Trial. PLoS ONE. 5(11). e13838–e13838. 35 indexed citations

Cohen, Joe, et al.. (2010). Le candidat vaccin antipaludique RTS,S/AS est entré en essais cliniques de phase III. Annales Pharmaceutiques Françaises. 68(6). 370–379. 6 indexed citations

10.

Reed, Steven G., Rhea N. Coler, Wilfried Dalemans, et al.. (2009). Defined tuberculosis vaccine, Mtb72F/AS02A, evidence of protection in cynomolgus monkeys. Proceedings of the National Academy of Sciences. 106(7). 2301–2306. 137 indexed citations

11.

Polhemus, Mark E., Shon Remich, Bernhards Ogutu, et al.. (2009). Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area. PLoS ONE. 4(7). e6465–e6465. 94 indexed citations

12.

Ofori‐Anyinam, Opokua, Marguerite Koutsoukos, Philippe Moris, et al.. (2009). The candidate tuberculosis vaccine Mtb72F/AS02A: Tolerability and immunogenicity in humans. Human Vaccines. 5(7). 475–482. 89 indexed citations

13.

Waitumbi, John, Samuel B. Anyona, Mark E. Polhemus, et al.. (2009). Impact of RTS,S/AS02A and RTS,S/AS01B on Genotypes of P. falciparum in Adults Participating in a Malaria Vaccine Clinical Trial. PLoS ONE. 4(11). e7849–e7849. 39 indexed citations

14.

Macete, Eusébio, Jahit Sacarlal, John J. Aponte, et al.. (2007). Evaluation of two formulations of adjuvanted RTS, S malaria vaccine in children aged 3 to 5 years living in a malaria-endemic region of Mozambique: a Phase I/IIb randomized double-blind bridging trial. Trials. 8(1). 11–11. 25 indexed citations

15.

Stewart, V. Ann, Douglas S. Walsh, Shannon McGrath, et al.. (2006). Cutaneous delayed-type hypersensitivity (DTH) in a multi-formulation comparator trial of the anti-falciparum malaria vaccine candidate RTS,S in rhesus macaques. Vaccine. 24(42-43). 6493–6502. 28 indexed citations

16.

Macete, Eusébio, John J. Aponte, Caterina Guinovart, et al.. (2006). Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1–4 in Mozambique. Tropical Medicine & International Health. 12(1). 37–46. 30 indexed citations

17.

Sun, Peifang, Robert Schwenk, Katherine White, et al.. (2003). Protective Immunity Induced with Malaria Vaccine, RTS,S, Is Linked to Plasmodium falciparum Circumsporozoite Protein-Specific CD4+ and CD8+ T Cells Producing IFN-γ. The Journal of Immunology. 171(12). 6961–6967. 183 indexed citations

18.

Daubersies, Pierre, Alan W. Thomas, Pascal Millet, et al.. (2000). Protection against Plasmodium falciparum malaria in chimpanzees by immunization with the conserved pre-erythrocytic liver-stage antigen 3. Nature Medicine. 6(11). 1258–1263. 138 indexed citations

19.

Doherty, J.F., M Pinder, Nadia Tornieporth, et al.. (1999). A phase I safety and immunogenicity trial with the candidate malaria vaccine RTS,S/SBAS2 in semi-immune adults in The Gambia.. American Journal of Tropical Medicine and Hygiene. 61(6). 865–868. 66 indexed citations

20.

Stoute, José A., M. Slaoui, D. Gray Heppner, et al.. (1997). A Preliminary Evaluation of a Recombinant Circumsporozoite Protein Vaccine againstPlasmodium falciparumMalaria. New England Journal of Medicine. 336(2). 86–91. 652 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact